Aureomycin in experimental Chesson strain vivax malaria.

SummaryAureomycin, although not a causative prophylactic against the Chesson strain of P. vivax, delayed the appearance of malaria in volunteers for at least 2 weeks as compared with controls. When given therapeutically in high dosage, the antibiotic had a delayed action against erythrocytic parasites, too slow to be of practical value. Infections were not cured.